by Alice McCarthy, Harvard Medical School Researchers have found that an existing drug, apilimod, prevented infection of human cells with the SARS-CoV-2 virus. Credit: Tomas Kirchhausen New lab-based studies show that two existing drugs, including one developed by a researcher at Harvard Medical School and Boston Children’s Hospital, inhibit SARS-CoV-2—the virus that causes COVID-19—from infecting...
The Vanderbilt Laboratory for Biosynthetic Studies, led by Brian Bachmann, professor of chemistry, has discovered a naturally occurring compound that is resilient to antibiotic resistance because of its rare properties. Antibiotic resistance, the ability of bacteria to evade antibiotic treatment, has been identified by the Centers for Disease Control and Prevention as one of the...
JOHNS HOPKINS MEDICINE RED STAIN IS ACE2. THE GREEN PROBE IS STAINING CK18, WHICH IS FOUND IN SUPPORTING CELLS AND MUCUS GLANDS. view more CREDIT: PHOTO BY MENGFEI CHEN Scientists at Johns Hopkins Medicine, experimenting with a small number of human cell samples, report that the “hook” of cells used by SARS-CoV-2 to latch onto...
by Kobe University A research group led by Professor Mori Yasuko (of the Division of Clinical Virology, Center for Infectious Diseases, Kobe University Graduate School of Medicine) has revealed that the HHV-6B glycoprotein complex gH/gL/gQ1/gQ2 is an effective vaccine candidate for human herpesvirus 6B (HHV-6B). There are still no methods to treat or prevent HHV-6B...
By Rich Haridy August 18, 2020 A new systematic review and meta-analysis from a trio of University of Oxford researchers is affirming the effectiveness of honey as a first-line treatment for upper respiratory tract infections (URTI). The study suggests antibiotics are ineffective for these kinds of minor coughs and colds, and honey offers superior symptomatic...
by RMIT University The study, conducted by an international team and led by RMIT University’s Professor Christian Doerig, outlines a strategy that could save years of drug discovery research and millions of dollars in drug development by repurposing existing treatments designed for other diseases such as cancer. The approach shows so much promise it has...
Boosting the immune system could offer a potential treatment strategy for COVID-19, according to a new study. As the COVID-19 pandemic continues to claim lives around the world, much research has focused on the immune system’s role in patients who become seriously ill. A popular theory has it that the immune system gets so revved...
by University of Aberdeen A new study conducted during the height of UK hospital admissions from COVID-19 has found that the regular use of painkillers including ibuprofen, naproxen and diclofenac did not increase the risk of death from the disease. Published in the Journal of Clinical Medicine, the study is the first to report on...
DZNE – GERMAN CENTER FOR NEURODEGENERATIVE DISEASES Contrary to what has been generally assumed so far, a severe course of COVID-19 does not solely result in a strong immune reaction – rather, the immune response is caught in a continuous loop of activation and inhibition. Experts from Charité – Universitätsmedizin Berlin, the University of Bonn,...
Sarecycline, a drug approved for use in the United States in 2018, is the first new antibiotic approved to treat acne in more than 40 years. Now, researchers at Yale and the University of Illinois-Chicago have discovered how its unique chemical structure makes it effective. Their new study is the most detailed biological analysis to...
